gracecast-083_lung-cancer_q&a with dr. lilenbaum on managing lung cancer in elderly patients
Published 12 years ago • 139 plays • Length 7:55Download video MP4
Download video MP3
Similar videos
-
41:20
gracecast-082_lung-cancer_challenges and special considerations in treating elderly patients
-
28:22
gracecast-088_lung-cancer_challenging cases in lung cancer: acquired resistance to egfr tki therapy
-
5:09
gracecastuc-013_lung_what should we do for a "mixed response" to lung cancer treatment?
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
10:10
gracecast-017_lung-cancer_never-smokers with lung cancer
-
33:18
gracecast-087_lung-cancer_detection and work-up of lung nodules, by david yankelevitz
-
4:35
the importance of biomarker testing: what is liquid biopsy? - targeted therapies in lung cancer 2023
-
26:56
gracecast-085_lung-cancer_alk inhibition: who to screen and options for alk-positive patients
-
1:49
q&a: when should a patient do biomarker retesting? - targeted therapies in lung cancer 2023
-
13:40
gracecast-104_lung-cancer_immunotherapy for lung cancer: q and a session
-
4:52
what is palliative care? - targeted therapies in lung cancer 2023
-
20:22
gracecast-089_lung-cancer_a history of tobacco and the rise of lung cancer, by dr. mark millard
-
13:44
gracecast-079_lung-cancer_challenging cases in lung cancer: unresectable locally advanced nsclc
-
5:10
gracecast - what is tumor mutational burden tmb and could it be helpful in lung cancer management to
-
10:57
gracecast-033_lung-cancer_individualizing treatment for nsclc
-
9:18
gracecast - treatment options for metastatic nsclc
-
15:54
gracecast-075_lung-cancer_ccilc - optimal treatment for stage iiia n2 node-positive nsclc
-
9:30
gracecast-037_lung-cancer_horton interview 1 - nsclc subtypes
-
20:34
gracecast-118_lung-cancer_asco 2012 lung cancer highlights: question and answer session
-
30:30
gracecast-008_lung-cancer_intro to surgery for nsclc
-
6:42
maintenance systemic therapy: the nrg-lu trial - onctalk lung 2023
-
15:20
gracecast-057_lung-cancer_expert round table - optimal nsclc treatment for elderly / frail